Neoadjuvant FLOT versus SOX chemotherapy in locally advanced gastric cancer: secondary outcomes of a single-centre, open-label, randomised, exploratory phase 2 trial
Authors
- Zhenglun Zhu (ORCID: https://orcid.org/0000-0003-4533-1893)
- Yanan Zheng (ORCID: https://orcid.org/0000-0002-9823-0191)
- Wentao Liu (ORCID: https://orcid.org/0000-0001-5534-7173)
- Chao Yan (ORCID: https://orcid.org/0000-0002-2691-7955)
- Birendra Kumar Sah (ORCID: https://orcid.org/0000-0002-7415-960X)
- Zhenggang Zhu (ORCID: https://orcid.org/0000-0002-4800-8082)
- Huan Zhang (ORCID: https://orcid.org/0000-0002-9838-0624)
- Jian Li (ORCID: https://orcid.org/0000-0002-5807-2360)
- Min Shi (ORCID: https://orcid.org/0000-0002-2130-181X)
- Benyan Zhang
- Fei Yuan
- Zhenjia Yu (ORCID: https://orcid.org/0000-0002-3270-6855)
- Chen Li (ORCID: https://orcid.org/0000-0002-4405-8306)
- Tao Ma (ORCID: https://orcid.org/0000-0003-3848-8438)
Institutions
- Shanghai Jiao Tong University (CN)
- Ruijin Hospital (CN)